跳至主要内容
临床试验/ISRCTN95571932
ISRCTN95571932进行中(未招募)Unknown

A prospective study to assess the impact and benefits of an AI system in double reading for breast cancer screening

Kheiron Medical Technologies (United Kingdom)0 个研究点目标入组 6,876 人开始时间: 2023年9月29日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
6,876

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Participants routinely invited or self-referred for breast screening
  • 2. Participants identified as female
  • 3. Participants for whom a 2D FFDM standard four-view mammography examination was acquired

排除标准

  • 1. Patients with cosmetic breast implants
  • 2. Very high risk patients, including genetic abnormalities etc.
  • 3. Patients who have actively dissented from participation in the study
  • 4. Cases marked as technical recall

研究者

发起方
Kheiron Medical Technologies (United Kingdom)

相似试验